BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15185593)

  • 1. [Inflammatory bowel diseases and lymphoma].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of lymphoma in inflammatory bowel disease.
    Loftus EV; Tremaine WJ; Habermann TM; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Am J Gastroenterol; 2000 Sep; 95(9):2308-12. PubMed ID: 11007233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of non-Hodgkin's lymphoma: recent data].
    Chassagne-Clément C; Blay JY; Treilleux I; Sebban C; Bergeron C; Biron P; Philip T
    Bull Cancer; 1999 Jun; 86(6):529-36. PubMed ID: 10417426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypothesis of occupational etiology of Hodgkin's and non-Hodgkin's lymphoma: a case-control study].
    Binaschi S; Santoro G; Introini U
    G Ital Med Lav; 1985; 7(5-6):181-6. PubMed ID: 3842815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease complicated by primary gastrointestinal Hodgkin's lymphoma presenting with small bowel perforation.
    Castrellon A; Feldman PA; Suarez M; Spector S; Chua L; Byrnes J
    J Gastrointestin Liver Dis; 2009 Sep; 18(3):359-61. PubMed ID: 19795032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of non-Hodgkin's lymphoma: why the increased incidence?
    Palackdharry CS
    Oncology (Williston Park); 1994 Aug; 8(8):67-73; discussion 73-8. PubMed ID: 7947004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epstein-Barr virus and Hodgkin's lymphoma].
    Hjalgrim H; Munksgaard L; Melbye M
    Ugeskr Laeger; 2002 Dec; 164(50):5924-7. PubMed ID: 12553111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
    Sokol H; Beaugerie L
    Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary].
    Keresztes K; Bessenyei B; Szöllosi Z; Beck Z; Miltényi Z; Nemes Z; Oláh E; Illés A
    Orv Hetil; 2005 Jul; 146(30):1575-82. PubMed ID: 16136734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.
    Swerdlow AJ
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S3-12. PubMed ID: 12734687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphoproliferative disorders in an inflammatory bowel disease unit].
    Van Domselaar M; López San Román A; Bastos Oreiro M; Garrido Gómez E
    Gastroenterol Hepatol; 2010 Jan; 33(1):12-6. PubMed ID: 19889478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?
    Bebb JR; Logan RP
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1843-9. PubMed ID: 11736713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
    Kwon JH; Farrell RJ
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):169-78. PubMed ID: 15979323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology.
    Müller AM; Ihorst G; Mertelsmann R; Engelhardt M
    Ann Hematol; 2005 Jan; 84(1):1-12. PubMed ID: 15480663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible Hodgkin's lymphoma associated with Epstein-Barr virus occurring during azathioprine therapy for SLE.
    Evans SJ; Watson DK; O'Sullivan M
    Rheumatology (Oxford); 2008 Jul; 47(7):1103-4. PubMed ID: 18469023
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
    Gupta G; Gelfand JM; Lewis JD
    Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epstein-Barr virus in a donor kidney as a cause of non-Hodgkin lymphoma].
    Kersten MJ; Surachno S; Koopman MG; van 't Veer LJ; Pals ST; van Oers MH
    Ned Tijdschr Geneeskd; 1999 Feb; 143(7):360-4. PubMed ID: 10221099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women.
    Zhang Y; Holford TR; Leaderer B; Boyle P; Zahm SH; Zhang B; Zou K; Morton LM; Owens PH; Flynn S; Tallini G; Zheng T
    Am J Epidemiol; 2004 Oct; 160(8):766-73. PubMed ID: 15466499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does smoking or alcohol modify the risk of Epstein-Barr virus-positive or -negative Hodgkin lymphoma?
    Willett EV; O'Connor S; Smith AG; Roman E
    Epidemiology; 2007 Jan; 18(1):130-6. PubMed ID: 17099321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.